THIS ADVANCE is made on 8 March 2022 and effective as of 8 March 2022 BETWEEN AND each a “Party” and together the “Parties” to this Advance. RECITALS THE PARTIES HEREBY agree as follows:Advance Agreement • March 14th, 2022 • Alvotech Lux Holdings S.A.S. • Biological products, (no disgnostic substances) • Luxembourg
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SETTLEMENT AND LICENSE AGREEMENTSettlement and License Agreement • March 14th, 2022 • Alvotech Lux Holdings S.A.S. • Biological products, (no disgnostic substances) • Illinois
Pursuant to Rule 42 of the Federal Rules of Appellate Procedures, the parties, by joint motion and agreement, request that this Court dismiss the above-captioned appeal, with prejudice, and with each party to bear its own costs and fees.
